Lipid Nanoparticles (LNPs) CDMO Market: Driving Innovation in Drug Delivery and Vaccine Development
The Lipid Nanoparticles (LNPs) CDMO Market encompasses the services provided by Contract Development and Manufacturing Organizations (CDMOs) to develop and produce lipid nanoparticles for pharmaceutical and biotech companies. Lipid nanoparticles are vital delivery systems used to encapsulate and transport therapeutic molecules, including mRNA, siRNA, and small drugs, into target cells. LNPs gained widespread attention as the delivery technology behind COVID-19 mRNA vaccines, but they also hold great promise for gene therapy, cancer treatments, and other advanced therapeutics.